STOCK TITAN

Science 37 to Report Third Quarter 2022 Financial Results on November 10, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Science 37 Holdings, Inc. (Nasdaq: SNCE) will release its third quarter 2022 financial results on November 10, 2022, after market close. A conference call for investors is scheduled for November 11, 2022, at 8:30 a.m. ET. Interested participants must register in advance to obtain dial-in details. Following the call, a replay will be available for 90 days. Science 37 aims to enhance clinical research accessibility, utilizing a technology platform that enables faster enrollment and better retention in decentralized clinical trials.

Positive
  • Science 37's technology allows up to 21x faster enrollment in clinical trials.
  • The company supports 28% better retention of trial participants.
Negative
  • None.

RESEARCH TRIANGLE PARK, N.C., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™ today announced it will report third quarter 2022 financial results after the market closes on Thursday, November 10, 2022. Company management will host a corresponding conference call on Friday, November 11, 2022, at 8:30 a.m. Eastern Time.

The conference call can be accessed by registering online for dial-in information or via live audio webcast at: https://investors.science37.com/news-events/events-presentations. Participants interested in dialing in to the conference call are requested to register a day in advance or at a minimum 15 minutes before the start of the call to obtain a unique pin for the call.

A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

About Science 37

Science 37 Holdings, Inc.’s (Nasdaq: SNCE) mission is to enable universal access to clinical research—making it easier for patients and providers to participate from anywhere and helping to accelerate the development of treatments that impact patient lives. As a pioneer of decentralized clinical trials, the Science 37 l Operating System (OS) supports today’s more agile clinical research designs with its full-stack, end-to-end technology platform and centralized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, provider communities, and data and devices. Configurable to enable almost any study type, the Science 37 OS enables up to 21x faster enrollment, 28% better retention, and 3x more diverse patient population with industry-leading workflow orchestration, evidence generation, and data harmonization. For more information, visit https://www.science37.com.

Contacts:

MEDIA INQUIRIES:
Drew Bustos
Science 37
Phone: (610) 417-6953
Email: pr@science37.com

INVESTOR RELATIONS:
Steve Halper
Managing Director
LifeSci Advisors
Phone: (646) 876-6455
Email: shalper@lifesciadvisors.com


FAQ

When will Science 37 report its Q3 2022 financial results?

Science 37 will report its Q3 2022 financial results on November 10, 2022, after market close.

What time is the Science 37 conference call for Q3 2022 results?

The conference call will take place on November 11, 2022, at 8:30 a.m. Eastern Time.

How can I access the Science 37 Q3 2022 financial results conference call?

Participants can register online for dial-in information or access the live audio webcast through Science 37's investor relations website.

What is the focus of Science 37's operations?

Science 37 focuses on enabling universal access to clinical research through its Agile Clinical Trial Operating System.

Science 37 Holdings, Inc.

NASDAQ:SNCE

SNCE Rankings

SNCE Latest News

SNCE Stock Data

34.66M
4.13M
16.89%
52.18%
0.23%
Health Information Services
Healthcare
Link
United States
Research Triangle Park